ResMed Inc.
Michael J. Farrell (Chairman and CEO) sells RMD shares
About this filing
ResMed Inc. (RMD) filed Form 4 (insider transaction) with the SEC on Oct 8, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Michael J. Farrell · Chairman and CEO, Director
Rule 10b5-1 plan · adopted Oct 31, 2024
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 7, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +4,991 | $146.34 | $730,382.94 | 484,794 | Direct |
| Oct 7, 2026 | S · open-market saleFootnotes F1, F2 | −4,991 | $226.33 | $1,129,637.49 | 479,803 | Direct |
| Oct 7, 2026 | M · exercise or conversion of a derivativeResMed Common Stock OptionsFootnotes F1, F3 | −4,991 | $0.00 | $0.00 | 4,993 | Direct |
Footnotes
- F1 The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.
- F2 This transaction was executed in multiple trades at prices ranging from $222.2135 - $227.581. The price reported above reflects the weighted average sale price.
- F3 Represents date options first become exercisable. Options vest 1/3 per year
More RMD filings
- 8-K
Filed Oct 29, 2026
- 10-Q
Filed Oct 29, 2026
- 4
Filed Oct 26, 2026
- 144
Filed Oct 23, 2026
- 144
Filed Oct 7, 2026
- ARS
Filed Oct 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.